AGO2 and cancer: CircAGO2 interacts with HuR protein to facilitate HuR activation and enrichment on the 3’ UTR of target mRNAs, which reduces the accessibility for AGO2 binding and AGO2/miRNA-mediated silencing to mRNAs associated with cancer progression [208].